ES8706146A1 - Un procedimiento para preparar derivados de piridina - Google Patents

Un procedimiento para preparar derivados de piridina

Info

Publication number
ES8706146A1
ES8706146A1 ES553370A ES553370A ES8706146A1 ES 8706146 A1 ES8706146 A1 ES 8706146A1 ES 553370 A ES553370 A ES 553370A ES 553370 A ES553370 A ES 553370A ES 8706146 A1 ES8706146 A1 ES 8706146A1
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
represents hydrogen
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553370A
Other languages
English (en)
Other versions
ES553370A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES553370A0 publication Critical patent/ES553370A0/es
Publication of ES8706146A1 publication Critical patent/ES8706146A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE PIRIDINA. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) O UN TAUTOMERO DEL MISMO CON A-CIANOACETAMIDA, PARA OBTENER DERIVADOS DE PIRIDINA DE FORMULA (I) DONDE R1 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR, UN GRUPO FENILO Y OTROS; R2 ES UN ATOMO DE HIDROGENO O UN ATOMO DE HALOGENO; R3 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR O UN HALOGENO; W ES UN ATOMO DE H O UN GRUPO ALQUILO INFERIOR; Y Z ES UN ATOMO DE H O UN GRUPO ALQUILO INFERIOR. TIENE APLICACIONES FARMACEUTICAS COMO CARDIOTONICOS.
ES553370A 1985-03-26 1986-03-25 Un procedimiento para preparar derivados de piridina Expired ES8706146A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60059450A JPS61218589A (ja) 1985-03-26 1985-03-26 ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体

Publications (2)

Publication Number Publication Date
ES553370A0 ES553370A0 (es) 1987-05-16
ES8706146A1 true ES8706146A1 (es) 1987-05-16

Family

ID=13113637

Family Applications (5)

Application Number Title Priority Date Filing Date
ES553370A Expired ES8706146A1 (es) 1985-03-26 1986-03-25 Un procedimiento para preparar derivados de piridina
ES557235A Expired ES8708230A1 (es) 1985-03-26 1986-12-01 Un procedimiento para preparar derivados de piridina
ES557236A Expired ES8708231A1 (es) 1985-03-26 1986-12-01 Un procedimiento para preparar derivados de piridina
ES557588A Expired ES8801655A1 (es) 1985-03-26 1987-06-15 Un procedimiento para preparar derivados de piridina
ES557587A Expired ES8801654A1 (es) 1985-03-26 1987-06-15 Un procedimiento para preparar derivados de piridina

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES557235A Expired ES8708230A1 (es) 1985-03-26 1986-12-01 Un procedimiento para preparar derivados de piridina
ES557236A Expired ES8708231A1 (es) 1985-03-26 1986-12-01 Un procedimiento para preparar derivados de piridina
ES557588A Expired ES8801655A1 (es) 1985-03-26 1987-06-15 Un procedimiento para preparar derivados de piridina
ES557587A Expired ES8801654A1 (es) 1985-03-26 1987-06-15 Un procedimiento para preparar derivados de piridina

Country Status (23)

Country Link
US (4) US4751227A (es)
EP (1) EP0199127B1 (es)
JP (1) JPS61218589A (es)
KR (1) KR930005005B1 (es)
CN (1) CN1020608C (es)
AT (1) ATE48603T1 (es)
AU (1) AU589410B2 (es)
CA (1) CA1309718C (es)
DD (2) DD263057A5 (es)
DE (1) DE3667466D1 (es)
DK (1) DK164788C (es)
ES (5) ES8706146A1 (es)
FI (1) FI86722C (es)
GR (1) GR860720B (es)
HU (1) HU198045B (es)
IE (1) IE59294B1 (es)
IL (1) IL78248A (es)
MX (1) MX163696B (es)
NO (1) NO163490C (es)
PH (1) PH22999A (es)
PT (1) PT82270B (es)
SU (1) SU1468420A3 (es)
ZA (1) ZA862259B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
JPH05503919A (ja) * 1989-06-13 1993-06-24 スミスクライン・ビーチャム・コーポレイション 単球および／またはマクロファージによるインターロイキン―１または腫瘍壊死因子生成の抑制
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
AU2010331175B2 (en) * 2009-12-18 2014-08-28 Mitsubishi Tanabe Pharma Corporation Novel antiplatelet agent
CN101830900B (zh) * 2010-05-27 2012-06-06 齐鲁制药(海南)有限公司 盐酸奥普力农晶型及其制备方法
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
CN102702197B (zh) * 2012-06-27 2014-12-03 武汉武药科技有限公司 盐酸奥普力农衍生物及其制备方法
CN102718747B (zh) * 2012-06-27 2014-06-11 武汉武药科技有限公司 盐酸奥普力农衍生物及其合成方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
KR102456567B1 (ko) 2013-08-09 2022-10-19 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
CN106349246B (zh) * 2016-08-29 2018-10-26 山东百诺医药股份有限公司 奥普力农及9-氮杂吲哚-5-硼酸的制备方法
CN108840866A (zh) * 2018-05-24 2018-11-20 河北宇辰医药科技有限公司 一种奥普力农类似物ⅰ的制备方法与用途
CN109575017A (zh) * 2018-11-01 2019-04-05 山东蒲济医药科技有限公司 一种盐酸奥普力农化合物的制备方法
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN111499631B (zh) * 2020-06-02 2021-07-30 济南康桥医药科技有限公司 一种盐酸奥普力农关键中间体1-咪唑并[1,2-a]吡啶-6-基-2-丙酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
PH22999A (en) 1989-02-24
CN1020608C (zh) 1993-05-12
FI861262A (fi) 1986-09-27
US4803276A (en) 1989-02-07
ES557588A0 (es) 1988-02-16
SU1468420A3 (ru) 1989-03-23
IE59294B1 (en) 1994-02-09
EP0199127B1 (en) 1989-12-13
IL78248A (en) 1989-09-10
KR930005005B1 (ko) 1993-06-11
IE860775L (en) 1986-09-26
JPS61218589A (ja) 1986-09-29
ES8801655A1 (es) 1988-02-16
MX163696B (es) 1992-06-15
PT82270B (pt) 1988-02-17
KR860007257A (ko) 1986-10-10
US4751227A (en) 1988-06-14
GR860720B (en) 1986-03-25
NO861190L (no) 1986-09-29
NO163490B (no) 1990-02-26
FI861262A0 (fi) 1986-03-25
FI86722C (fi) 1992-10-12
ZA862259B (en) 1986-11-26
AU589410B2 (en) 1989-10-12
ES8801654A1 (es) 1988-02-16
DK164788B (da) 1992-08-17
ES557587A0 (es) 1988-02-16
EP0199127A1 (en) 1986-10-29
CA1309718C (en) 1992-11-03
US4791203A (en) 1988-12-13
ES8708230A1 (es) 1987-10-01
DK137786A (da) 1986-09-27
US4791202A (en) 1988-12-13
DE3667466D1 (de) 1990-01-18
DD283390A5 (de) 1990-10-10
IL78248A0 (en) 1986-07-31
HUT41026A (en) 1987-03-30
ATE48603T1 (de) 1989-12-15
ES557235A0 (es) 1987-10-01
JPH0558437B2 (es) 1993-08-26
DK137786D0 (da) 1986-03-25
PT82270A (en) 1986-04-01
ES553370A0 (es) 1987-05-16
NO163490C (no) 1990-06-06
CN86102812A (zh) 1986-11-26
HU198045B (en) 1989-07-28
AU5507286A (en) 1986-10-02
ES557236A0 (es) 1987-10-01
DK164788C (da) 1992-12-28
ES8708231A1 (es) 1987-10-01
DD263057A5 (de) 1988-12-21
FI86722B (fi) 1992-06-30

Similar Documents

Publication Publication Date Title
ES8801655A1 (es) Un procedimiento para preparar derivados de piridina
AU4929690A (en) Phenyl pyradazine-3(2H)one, thiadizin-2(3H)one, triazin-3(2H) one and oxadiazin-5(4H)one derivatives for the treatment of congestive heart failure
AU7810787A (en) 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
CS8800891A2 (en) Method of imidazole's new derivatives production
FI921298A (fi) Menetelmä lääkeaineena käyttökelpoisen 5-(6-imidatso/1,2-a/pyridyyli)pyridiini-johdannaisen valmistamiseksi